N/A
N=68
Ceramic-on-ceramic THA for Post-traumatic Hip Osteoarthritis After Acetabular Fracture
Hip Osteoarthritis · Post-traumatic Osteoarthritis
Bottom Line
View on ClinicalTrials.gov: NCT04034043 ↗Enrolled (actual)
68
Serious AEs
11.8%
Results posted
Nov 2019
Primary outcome: Primary: Survival Rates of the Hip Implants — 96.3 percentage of non-revised implants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- ceramic-on-ceramic total hip arthroplasty (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Istituto Ortopedico Rizzoli
- Primary completion
- Jul 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Survival Rates of the Hip Implants |
96.3 | — |
| PRIMARY Clinical Outcomes of the Hip Implants |
84.3 | — |
| PRIMARY Clinical Outcomes of the Hip Implants |
84.3 | — |
| PRIMARY Percentage of Patients With Adequate Radiographic Cup Osseointegration |
68 | — |
Summary
A retrospective consecutive population of patients treated with cementless total hip arthroplasty with ceramic-on-ceramic bearing surfaces due to post-traumatic osteoarthritis due to acetabular fractures will be selected. The aim of this retrospective study is to evaluate the long-term clinical and radiographic results of this implant in such a specific cohort. The secondary aim of the sudy is to provide the complication rate and the failure rate of the cohort. A descriptive analysis of the failures will be provided as well.
Eligibility Criteria
Inclusion Criteria
- symptomatic, post-traumatic hip osteoarthritis due to acetabular fracture
- consecutive population with a minimum follow-up of 10 years
- cementless total hip arthroplasty with ceramic-on-ceramic bearing surfaces
- pre-operative planning using CT
- complete clinical and radiographic assessment
Exclusion Criteria
- other type of hip osteoarthritis
- other type of implants
- inadequate pre-operative planning (eg: no CT)
- incomplete assessment
Data sourced from ClinicalTrials.gov (NCT04034043). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.